Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 538,202 | 683,971 | 565,748 | 573,463 | 535,955 |
| Gross Profit | 538,202 | 683,971 | 565,748 | 573,463 | 535,955 |
| Operating Expenses | 289,362 | 204,999 | 1,048,403 | 381,253 | 158,163 |
| Operating Income | 248,840 | 478,972 | -482,655 | 192,210 | 377,792 |
| Interest Expense | 46,949 | 46,950 | 46,955 | 46,977 | 46,966 |
| Other Income | 149,445 | 77,067 | -80,420 | 75,181 | 160,771 |
| Pre-tax Income | 351,336 | 509,089 | -610,030 | 220,414 | 491,597 |
| Net Income Continuous | 351,336 | 509,089 | -610,030 | 220,414 | 491,597 |
| Minority Interests | 123,711 | 168,334 | -153,946 | 77,763 | 187,093 |
| Net Income | $227,625 | $340,755 | $-456,084 | $142,651 | $304,504 |
| EPS Basic Total Ops | 0.51 | 0.76 | -1.04 | 0.32 | 0.70 |
| EPS Basic Continuous Ops | 0.78 | 1.14 | -1.40 | 0.50 | 1.13 |
| EPS Diluted Total Ops | 0.50 | 0.76 | -1.04 | 0.32 | 0.70 |
| EPS Diluted Continuous Ops | 0.58 | 0.84 | -0.86 | 0.36 | 0.81 |
| EPS Diluted Before Non-Recurring Items | 0.85 | 1.60 | 1.56 | N/A | N/A |
| EBITDA(a) | $254,163 | $484,296 | $-477,325 | $197,553 | $383,132 |